Invesaro

Stocks MTEX Financial statements

Financial statements

MANNATECH INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MANNATECH INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue180177174158151160137132118108
Cost of revenue36.635.734.531.635.534.133.129.126.427.1
Gross profit14414113912611612610410391.581
Research and development1.41.211.10.81.210.80.70.8
Selling, general and administrative41.739.7
Selling and marketing24.819.7
General and administrative37.235.534.230.827.829.447.450.241.7
Operating expenses1431391391201111171051049081.4
Operating income0.662.52-0.096.434.499.05-0.41-0.961.43-0.43
Interest expense0.280.41
Other non-operating income-1.79-0.330.29-0.681.15-0.22-0.16-0.172.59-2.06
Pre-tax income-0.962.460.495.745.738.89-0.48-1.133.74-2.89
Income tax-0.374.254.382.45-0.54-0.954.011.111.2512.3
Net income-0.59-1.79-3.893.296.269.84-4.49-2.242.49-15.2
EBITDA2.564.381.978.526.4810.81.220.662.960.67
EPS, basic-0.22-0.66-1.531.382.804.95-2.35-1.201.32-8.00
EPS, diluted-0.22-0.66-1.531.352.774.71-2.35-1.201.32-8.00
Shares, basic (weighted)2.692.712.542.392.241.991.911.871.891.9
Shares, diluted (weighted)2.692.712.542.442.262.091.911.871.891.9
Dividend per share0.20

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents28.737.721.824.822.224.213.87.7311.46.19
Receivables0.30.270.110.960.190.10.20.090.020
Inventory129.3912.810.212.81214.714.510.410.1
Other current assets3.482.613.369.6129.28.41.771.761.7
Total current assets50.856.242.44142.542.83527.726.120.6
Property, plant and equipment4.624.316.766.135.364.243.764.152.712.23
Lease right-of-use assets5.66.94.74.63.322.093.29
Intangible assets0.240.24
Other non-current assets4.013.883.899.59129.228.443.752.642.75
Total assets71.276.262.262.965.359.649.141.236.130
Accounts payable5.226.016.723.534.83.974.364.012.072.41
Accrued liabilities5.615.7768.218.699.227.515.123.833.13
Deferred revenue8.168.565.274.425.474.875.114.793.033.09
Total current liabilities3033.433.628.93230.129.825.820.918.7
Long-term debt0.5700.880.36002.92.75
Lease liabilities5.36.14.34.22.581.582.25
Other non-current liabilities1.471.272.36.217.255.055.031.41.391.34
Total liabilities32.33636.935.639.435.23530.727.435.2
Total debt2.75
Paid-in capital38.234.933.934.133.833.333.433.33333
Retained earnings7.334.19-2.78-0.692.217.711.69-1.31.19-14
Treasury stock-8.47-4.86-10.2-9.94-15.2-18.9-20.7-20.5-19.9-19.6
Other comprehensive income1.835.984.343.765.152.34-0.21-1.02-5.67-4.67
Shareholders' equity38.940.225.327.32624.414.210.58.61-5.22
Total equity38.940.225.327.32624.414.210.58.61-5.22
Total liabilities and equity71.276.262.262.965.359.649.141.236.130
Shares outstanding2.692.72.382.382.071.941.861.861.881.9

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-0.59-1.79-3.893.296.269.84-4.49-2.242.49-15.2
Depreciation and amortization1.91.862.062.091.991.721.631.631.531.09
Stock-based compensation0.690.491.150.730.330.260.340.280.290.38
Deferred income tax-1.472.141.171.06-0.28-1.731.230.12-0.1611.5
Change in receivables-0.5-0.31-0.38-0.930.56-0.15-0.1-0.390.340.17
Change in inventory-3.152.38-4.152.05-2.660.17-3.25-0.272.470.31
Change in payables2.550.710.72-3.21.27-0.830.39-0.35-1.860.32
Cash from operations-0.0210.3-0.224.926.0310.8-2.6-2.372.26-2.96
Capital expenditures-2.29-1.34-2.34-1.22-0.95-0.65-1.06-0.75-0.3-1.35
Cash from investing-2.29-1.34-2.28-1.22-0.95-0.65-1.06-0.75-0.29-1.35
Stock issued0.040.080.11000.5500.010
Share buybacks-0.27-0.23-7.54-0.29-5.93-5.05-1.98-0.180
Dividends paid-0.67-1.35-3.09-1.2-3.36-4.35-1.53-0.750
Cash from financing-2.46-3.06-12.1-2.71-9.92-9.29-4.33-1.91.96-0.56
Exchange rate effect1.464.21-1.62-0.571.33-2.7-2.44-0.79-0.81
Net change in cash-3.3110.1-16.20.42-3.5-1.87-10.4-5.813.13-5.55
Free cash flow-2.318.98-2.563.75.0810.1-3.66-3.121.96-4.32
Interest paid0.480.51
Income taxes paid1.781.690.810.990.140.722.550.830.43

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.70 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin76.1%Gross profit / revenue.
Operating margin2.5%Operating income / revenue.
EBITDA margin3.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin4.7%Pre-tax income / revenue.
Net margin-6.9%Net income / revenue.
FCF margin1.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.3%Cash from operations / revenue.
Effective tax rate248.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)-27.0%Net income / average total assets.
SG&A / revenue34.6%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.8%Capital expenditures / revenue.
D&A / revenue1.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-8.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-7.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-6.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-11.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-8.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-6.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-129.8%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-77.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-18.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-36.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-711.0%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-706.1%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-231.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-319.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-160.6%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-16.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-15.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-14.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.15xCurrent assets / current liabilities.
Quick ratio0.37x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.36x(Cash + short-term investments) / current liabilities.
Debt / assets10.0%Total debt / total assets.
Liabilities / assets118.1%Total liabilities / total assets.
Net debt-$3.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.89xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.90xOperating income / interest expense.
Working capital$2.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$5.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover3.91xRevenue / average total assets.
Fixed asset turnover39.1xRevenue / average property, plant and equipment.
Inventory turnover2.68xCost of revenue / average inventory.
Days inventory136 days365 x average inventory / cost of revenue.
Receivables turnover784xRevenue / average receivables.
Days sales outstanding0 days365 x average receivables / revenue.
Days payables52 days365 x average accounts payable / cost of revenue.
Cash conversion cycle85 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow35.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.84Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$55.63Revenue / diluted weighted shares.
FCF per share$0.83Free cash flow / diluted weighted shares.
Operating cash flow per share$1.27Cash from operations / diluted weighted shares.
Book value per share-$2.58Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$2.70Tangible book value / shares outstanding.
Cash per share$3.13(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$14.9MShare price x shares outstanding.
Enterprise value$11.6MMarket cap + total debt - cash - short-term investments.
P/S0.14xMarket cap / revenue.
P/FCF9.31xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF6.05xMarket cap / cash from operations, when positive.
EV/Sales0.11xEnterprise value / revenue.
EV/EBIT4.34xEnterprise value / operating income, when both are positive.
EV/EBITDA3.12xEnterprise value / EBITDA, when both are positive.
EV/FCF7.25xEnterprise value / free cash flow, when both are positive.
FCF yield10.7%Free cash flow / market cap.
Earnings yield-49.8%Net income / market cap (the inverse of P/E).
What was MANNATECH INC's revenue in fiscal 2025?

MANNATECH INC reported revenue of $108.0M for fiscal 2025, 8.3% lower than the year before.

Was MANNATECH INC profitable in fiscal 2025?

No. It reported a net loss of $15.2M.

How much free cash flow did MANNATECH INC generate in fiscal 2025?

Cash from operations of $3.0M minus capital expenditures of $1.4M left free cash flow of -$4.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MANNATECH INC